Laitman Y - Search Results

1

The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel.

Hassin-Baer S, Laitman Y, Azizi E, Molchadski I, Galore-Haskel G, Barak F, Cohen OS, Friedman E. Hassin-Baer S, et al. Among authors: laitman y. J Neurol. 2009 Mar;256(3):483-7. doi: 10.1007/s00415-009-0117-x. Epub 2009 Mar 24. J Neurol. 2009. PMID: 19412725

2

Monoclonal origin of anatomically distinct basal cell carcinomas.

Shulman O, Laitman Y, Vilan A, Leviav A, Friedman E. Shulman O, et al. Among authors: laitman y. J Invest Dermatol. 2006 Mar;126(3):676-9. doi: 10.1038/sj.jid.5700130. J Invest Dermatol. 2006. PMID: 16410785 Free article.

3

The 471delAAAG mutation and C353T polymorphism in the RNASEL gene in sporadic and inherited cancer in Israel.

Dagan E, Laitman Y, Levanon N, Feuer A, Sidi AA, Baniel J, Korach Y, Ben Baruch G, Friedman E, Gershoni-Baruch R. Dagan E, et al. Among authors: laitman y. Fam Cancer. 2006;5(4):389-95. doi: 10.1007/s10689-006-0010-z. Epub 2006 Aug 31. Fam Cancer. 2006. PMID: 16944274

4

The P1812A and P25T BRCA1 and the 5164del4 BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews.

Kaufman B, Laitman Y, Carvalho MA, Edelman L, Menachem TD, Zidan J, Monteiro AN, Friedman E. Kaufman B, et al. Among authors: laitman y. Genet Test. 2006 Fall;10(3):200-7. doi: 10.1089/gte.2006.10.200. Genet Test. 2006. PMID: 17020472

5

A novel MSH2 germline mutation in a Druze HNPCC family.

Zidan J, Niessen RC, Laitman Y, Rozeveld D, Hofstra RM, Friedman E. Zidan J, et al. Among authors: laitman y. Fam Cancer. 2008;7(2):135-9. doi: 10.1007/s10689-007-9157-5. Epub 2007 Jul 29. Fam Cancer. 2008. PMID: 17661183

6

Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.

Laitman Y, Kaufman B, Lahad EL, Papa MZ, Friedman E. Laitman Y, et al. Isr Med Assoc J. 2007 Nov;9(11):791-6. Isr Med Assoc J. 2007. PMID: 18085035 Free article.

7

Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women.

Distelman-Menachem T, Shapira T, Laitman Y, Kaufman B, Barak F, Tavtigian S, Friedman E. Distelman-Menachem T, et al. Among authors: laitman y. Fam Cancer. 2009;8(2):127-33. doi: 10.1007/s10689-008-9216-6. Epub 2008 Sep 17. Fam Cancer. 2009. PMID: 18798010

8

SULT1E1 and ID2 genes as candidates for inherited predisposition to breast and ovarian cancer in Jewish women.

Cohen S, Laitman Y, Kaufman B, Milgrom R, Nir U, Friedman E. Cohen S, et al. Among authors: laitman y. Fam Cancer. 2009;8(2):135-44. doi: 10.1007/s10689-008-9218-4. Epub 2008 Sep 27. Fam Cancer. 2009. PMID: 18821033

9

MC1R variant alleles and malignant melanoma risk in Israel.

Galore-Haskel G, Azizi E, Mohamdi H, Scope A, Chaudru V, Laitman Y, Barak F, Pavlotsky F, Demenais F, Friedman E. Galore-Haskel G, et al. Among authors: laitman y. Eur J Cancer. 2009 Jul;45(11):2015-22. doi: 10.1016/j.ejca.2009.02.001. Epub 2009 Mar 5. Eur J Cancer. 2009. PMID: 19269164

10

The RNF146 and ECHDC1 genes as candidates for inherited breast and ovarian cancer in Jewish Ashkenazi women.

Menachem TD, Laitman Y, Kaufman B, Friedman E. Menachem TD, et al. Among authors: laitman y. Fam Cancer. 2009;8(4):399-402. doi: 10.1007/s10689-009-9255-7. Epub 2009 Jun 11. Fam Cancer. 2009. PMID: 19517271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters